Cite
HARVARD Citation
Peters, N. et al. (n.d.). Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial. European journal of cancer. pp. S117-S118. [Online].